DE:MEVIS
MeVis Medical Solutions AG
- Stock
Last Close
24.20
12/11 16:36
Market Cap
46.23M
Beta: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 90.50K - | ||||||||||
average payables | 990K - | 707.50K 28.54% | 566K 20% | 416K 26.50% | 307.50K 26.08% | 173.28K 43.65% | 51.66K 70.19% | 166.25K 221.85% | 216.16K 30.02% | 134.65K 37.71% | |
average receivables | 2.22M - | ||||||||||
book value per share | 15.35 - | 17.57 14.46% | 18.84 7.19% | 17.86 5.17% | 17.61 1.39% | 9.79 44.40% | 9.79 0% | 9.79 0% | 9.79 0% | ||
capex per share | -1.08 - | -0.91 15.95% | -0.06 92.85% | -0.12 87.44% | -0.11 5.88% | -0.11 2.44% | -0.06 49.46% | -0.03 50.41% | -0.07 161.69% | ||
capex to depreciation | -0.86 - | -0.92 6.52% | -0.06 93.50% | -0.18 203.39% | -0.23 26.01% | -0.79 246.37% | -0.61 22.75% | -0.41 33.81% | -1.43 252.99% | -0.83 41.85% | |
capex to operating cash flow | -0.25 - | -0.32 30.19% | -0.02 94.54% | -0.03 71.19% | -0.04 24.85% | -0.03 17.70% | -0.04 14.46% | -0.01 84.30% | -0.03 391.94% | -0.01 50.30% | |
capex to revenue | -0.13 - | -0.12 6.15% | -0.01 93.92% | -0.01 64.56% | -0.01 4.13% | -0.01 9.54% | -0.01 46.68% | -0.00 47.60% | -0.01 126.15% | -0.00 35.20% | |
cash per share | 8.20 - | 10.19 24.25% | 14.34 40.69% | 16.34 13.97% | 1.91 88.31% | 1.43 25.22% | 2.17 52.05% | 4.19 92.76% | 5.12 22.30% | ||
days of inventory on hand | |||||||||||
days payables outstanding | 446.76 - | 333.34 25.39% | 329.81 1.06% | 201.25 38.98% | 258.73 28.56% | 8.44 96.74% | 54.06 540.58% | 200.32 270.58% | 94.15 53.00% | 62.91 33.18% | |
days sales outstanding | |||||||||||
debt to assets | 0.01 - | 0.01 16.35% | 0.10 1,307.26% | 0.19 83.34% | 0.04 77.92% | ||||||
debt to equity | 0.01 - | 0.01 18.67% | 0.14 1,403.78% | 0.29 104.95% | 0.05 82.47% | ||||||
dividend yield | 0.00 - | 0.15 - | 0.03 80.16% | 0.03 9.08% | 0.10 254.18% | 0.07 24.03% | |||||
earnings yield | 0.10 - | 0.12 14.13% | 0.16 31.63% | 0.08 49.60% | 0.12 45.86% | 0.15 29.17% | 0.10 33.77% | 0.08 22.26% | 0.13 63.33% | ||
enterprise value | 25.70M - | 22.20M 13.60% | 22.10M 0.48% | 50.81M 129.97% | 60.39M 18.84% | 51.64M 14.49% | 53.92M 4.43% | 51.71M 4.10% | 52.92M 2.34% | -7.74M 114.63% | |
enterprise value over ebitda | 4.20 - | 3.24 22.79% | 3.10 4.30% | 6.00 93.69% | 7.17 19.47% | 6.13 14.54% | 9.03 47.22% | 9.62 6.58% | 6.64 31.01% | -1.50 122.56% | |
ev to operating cash flow | 3.43 - | 4.60 33.83% | 3.36 26.94% | 6.94 106.64% | 10.94 57.65% | 7.89 27.87% | 18.66 136.50% | 5.66 69.65% | 10.90 92.39% | -1.32 112.14% | |
ev to sales | 1.76 - | 1.70 3.53% | 1.38 18.64% | 2.74 98.64% | 3.60 31.48% | 2.86 20.71% | 3.15 10.17% | 3.19 1.32% | 2.82 11.55% | -0.45 115.83% | |
free cash flow per share | 3.27 - | 1.90 41.87% | 3.61 90.12% | 3.90 8.09% | 2.92 25.20% | 3.48 19.36% | 1.53 56.05% | 4.99 225.78% | 2.60 47.97% | ||
free cash flow yield | 0.16 - | 0.10 34.23% | 0.15 43.42% | 0.10 33.67% | 0.09 14.46% | 0.12 36.99% | 0.05 58.81% | 0.15 217.78% | 0.08 50.41% | ||
graham net net | 3.60 - | 5.55 54.37% | 7.74 39.25% | 7.24 6.46% | -1.58 121.89% | -1.92 21.18% | -3.30 72.07% | -1.15 65.29% | -2.23 94.34% | ||
graham number | 27.17 - | 29.20 7.45% | 39.93 36.76% | 35.24 11.75% | 39.52 12.15% | 31.26 20.89% | 26.28 15.93% | 23.46 10.73% | 30.71 30.90% | ||
income quality | 1.86 - | 1.24 33.18% | 1.47 18.55% | 0.92 37.52% | 0.82 10.34% | 0.81 1.68% | 0.51 37.52% | 2.01 296.48% | 0.62 68.95% | 1.19 90.81% | |
intangibles to total assets | 0.48 - | 0.41 14.22% | 0.30 25.52% | 0.24 21.47% | 0.29 21.15% | 0.00 99.73% | 0.00 88.63% | 0.00 85.92% | 0.00 59.51% | 0 100% | |
interest coverage | 27.20 - | 62.74 130.65% | 67.73 7.95% | 103.40 52.67% | 88.08 14.82% | 829.82 842.13% | 495.07 40.34% | 485.12 2.01% | 2.05K 321.71% | 118.55 94.21% | |
interest debt per share | 0.26 - | 0.20 23.67% | 2.69 1,240.58% | 5.19 93.27% | 0.93 82.05% | 0.01 99.42% | 0.01 19.19% | 0.01 7.73% | 0.00 64.40% | ||
inventory turnover | |||||||||||
invested capital | 0.01 - | 0.01 18.67% | 0.14 1,403.78% | 0.29 104.95% | 0.05 82.47% | ||||||
market cap | 35.28M - | 31.18M 11.62% | 42.97M 37.81% | 71.18M 65.63% | 62.24M 12.55% | 54.24M 12.87% | 57.88M 6.71% | 59.33M 2.52% | 62.24M 4.91% | ||
net current asset value | 9.58M - | 12.70M 32.65% | 16.90M 33.03% | 16.85M 0.32% | 795K 95.28% | 1.03M 29.19% | 1.09M 6.32% | 1.17M 6.84% | 1.13M 3.43% | 1.14M 1.43% | |
net debt to ebitda | -1.57 - | -1.31 16.28% | -2.93 123.47% | -2.41 17.84% | -0.22 90.83% | -0.31 39.88% | -0.66 114.35% | -1.42 114.23% | -1.17 17.56% | -1.50 28.08% | |
net income per share | 2.14 - | 2.16 0.87% | 3.76 74.49% | 3.09 17.87% | 3.94 27.55% | 4.43 12.55% | 3.13 29.33% | 2.50 20.31% | 4.28 71.35% | ||
operating cash flow per share | 4.34 - | 2.80 35.44% | 3.68 31.04% | 4.02 9.49% | 3.03 24.62% | 3.60 18.54% | 1.59 55.84% | 5.02 215.97% | 2.67 46.80% | ||
payables turnover | 0.82 - | 1.09 34.03% | 1.11 1.07% | 1.81 63.88% | 1.41 22.22% | 43.25 2,965.99% | 6.75 84.39% | 1.82 73.01% | 3.88 112.78% | 5.80 49.65% | |
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.20 - | 0.16 19.73% | 0.21 29.53% | 0.15 29.18% | 0.26 74.53% | 0.34 28.56% | 0.21 39.21% | 0.17 19.57% | 0.25 51.21% | 0.18 29.75% | |
revenue per share | 8.49 - | 7.60 10.44% | 8.94 17.67% | 10.19 13.90% | 9.21 9.61% | 9.93 7.85% | 9.41 5.21% | 8.91 5.35% | 10.31 15.71% | ||
roe | 0.14 - | 0.12 11.88% | 0.20 62.79% | 0.17 13.40% | 0.22 29.35% | 0.45 102.41% | 0.32 29.33% | 0.26 20.31% | 0.44 71.35% | 0.28 36.84% | |
roic | 0.15 - | 0.10 34.40% | 0.16 65.95% | 0.15 5.62% | 0.20 31.72% | 0.45 130.79% | 0.32 29.27% | 0.29 9.84% | 0.44 51.23% | 0.28 36.34% | |
sales general and administrative to revenue | 0.03 - | 0.03 5.18% | 0.05 94.69% | 0.01 74.03% | 0.01 28.23% | 0.03 223.65% | 0.04 31.68% | 0.05 12.76% | 0.02 47.44% | 0.03 7.70% | |
shareholders equity per share | 15.35 - | 17.57 14.46% | 18.84 7.19% | 17.86 5.17% | 17.61 1.39% | 9.79 44.40% | 9.79 0% | 9.79 0% | 9.79 0% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | 10.08M - | 14.65M 45.30% | 19.88M 35.67% | 20.79M 4.60% | 20.94M 0.74% | 17.81M 14.97% | 17.82M 0.09% | 17.83M 0.01% | 17.83M 0.00% | 17.83M 0.00% | |
tangible book value per share | 5.85 - | 8.50 45.30% | 11.10 30.51% | 11.42 2.91% | 11.51 0.74% | 9.78 14.97% | 9.79 0.09% | 9.79 0.01% | 9.79 0.00% | ||
working capital | 11.58M - | 15.31M 32.13% | 17.05M 11.39% | 17.15M 0.57% | 1.12M 93.46% | 3.56M 217.54% | 3.58M 0.52% | 4.22M 17.81% | 4.83M 14.48% | 4.52M 6.38% |
All numbers in (except ratios and percentages)